Canadian Cardiovascular Society

Upcoming Events

Only attendance to the live accredited event permits for a Certificate of Participation and Royal College Maintenance of Certification (MOC) Section 1 Group Learning credits to be claimed. For information on how recorded activities fit into the Royal College MOC Program, please visit: https://www.royalcollege.ca/en/cpd/moc-program  

To view recordings of past CCS CPD events, please visit: https://ccs.ca/recorded-events/  

 

Section 1 EventsDateNumber of Section 1 Credits
HVD Learning Series: Part 1 – Heart Valve Disease: Improving Recognition and Timely Diagnosis November 27, 20241
Canadian Perspectives on the AHA 2024 December 4, 20241
CCS-CSE Joint Webinar – Empowering Echocardiographers: Mastering Imaging Skills for Transcatheter Mitral Valve Procedures December 5, 20241
HCM Learning Series 3.0 Session 3December 11, 20241
CCS-CSE Joint Program #2 – Tricuspid WebinarJanuary 29, 20241
Section 3 EventsAvailable UntilNumber of Section 3 Hours
Hypertrophic Cardiomyopathy Learning Series 3.0: Part 1 – Navigating the Complexities of HCM Management: A Comprehensive Approach July 2027 1
Amyloid Education Series Part 1: Detecting Cardiac Amyloidosis: A Diagnostic OdysseyJune 20271
PH 2.0 Session 2 – Screening for Pulmonary Hypertension: Echocardiography is the Key to Detection May 20271
PH 2.0 Session 1 – Breathless: Navigating the Complexities of Pulmonary Hypertension Diagnosis and Management March 20271
HCM 2.0 – Session 3: From Guidelines to Breakthroughs: Optimizing Treatment Options for Patients with HCMJanuary 20271
A New Lens on ATTR-CM: Early Diagnosis & High-Risk PopulationsJanuary 20271
Adverse Cardiovascular Outcomes Associated with Viral Infections and the Role of Immunization in Protecting Patients at Increased RiskJanuary 20271
Inflammation and Vascular Risk at the Interface of Atherosclerosis, CKD, and Heart FailureJanuary 20271
Empowering Diabetes Care During Pregnancy: Unleashing the Potential of CGMJanuary 20271
Basal Insulin in Type 2 Diabetes Treatment: What’s Next?January 20271
Who Is the Appropriate Patient for GLP-1 RAs? Exploring the Role of the GLP-1 RA Class in Cardiometabolic HealthJanuary 20271
HCM 2.0 – Session 2: Unraveling the Puzzle – A Comprehensive Approach to Initial Management of Symptomatic HCMNovember 20261
HCM 2.0 – Session 1: Expressions in HCM: Strategies to Develop a Differential Diagnosis and the Value of Initial TestingMay 20261
Hypertrophic Cardiomyopathy Learning Series – Part 3: Therapeutics in HCMJanuary 20261
Part 3: CCS/CSE Pulmonary Hypertension: Diagnosis and Management of the PH Patient: Pathway to Collaborative CareJanuary 20261
New Cardiorenal Guidelines in Action: A Practical CaseJanuary 20261
Does Ejection Fraction Even Matter Anymore?January 20261
GDMT News Hour: Innovations in Heart Failure Management in CanadaJanuary 20261
The Other Pandemic: How can we Leverage Revolutionary Technology to Disrupt CV Disease?January 20261
Part 2: CCS/CSE Pulmonary Hypertension: Echocardiographic Assessment in Context: Tips and TricksNovember 20251
Hypertrophic Cardiomyopathy Learning Series – Part 2: Risk Stratification in Hypertrophic CMPNovember 20251
Hypertrophic Cardiomyopathy Learning Series – Part 1: HCM in Everyday PracticeJune 20251
Pulmonary Hypertension: Medical and Imaging Updates – Part 1: A Patient’s ExperienceJune 20251
Back to top